Biogen (BIIB)

EBITDA Growth

-42.15%

TTM · Period ending:

BIIB logo

BIIB EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-42.15%
BIIB TTM EBITDA YoY % (19.83% → -42.15%)
High-resolution chart · PNG

BIIB ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Biogen EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-12.3419%
-11.0057%
-6.403%
16.0846%
36.2819%
49.4699%
55.6563%
42.4916%
40.5134%
32.8229%
28.807%
69.1718%
46.2879%
88.4687%
149.2757%
142.4793%
681.6216%
303.4433%
135.2837%
143.2594%
4,256.5702%
54,141.1765%
242.1992%
230.418%
-96.9662%
-100.1896%
-63.7584%
-132.363%
-74.9153%
-42.6439%
-23.5795%
595.2381%
4,033.3333%
3,808.3333%
802.5641%
31.25%
-122.0588%
-78.1818%
-11.3636%
2,233.3333%
319.3548%
48.6486%
-58.8785%
97.8571%
62.6506%
139.3617%
189.916%
12.5%
53.3708%
57.0776%
51.0288%
42.8571%
38.8316%
23.9583%
16.7808%
29.2929%
19.8347%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.